Skip to content

Brain Maturation and Sleep

Exploring Diurnal Changes in Markers of Cortical Plasticity Using Multimodal Imaging in Healthy Children, Adolescents and Adults

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02685891
Acronym
BMS
Enrollment
90
Registered
2016-02-19
Start date
2016-06-30
Completion date
2025-12-31
Last updated
2024-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

In this study, the investigator evaluates whether there are age-specific diurnal changes in markers of cortical plasticity in children, adolescents and adults. The question will be investigated by the quantification of brain metabolites and structural brain volumes using magnet resonance imaging (MRI) and electrophysiological markers using sleep encephalography (sleep EEG). In a second step, it will be tested how these markers of cortical plasticity change depending on a modulation of sleep by applying tones during deep sleep.

Detailed description

Given that children and adolescents undergo entirely different maturational processes (children show an increase, adolescents a decrease in synapse density) larger diurnal changes in children are expected compared to adolescents concerning brain metabolites and structural markers. These cortical changes in synapse density are thought to be reflected in electrophysiological markers in the sleep EEG (children show a higher slow wave activity, adolescents a reduced slow wave activity). With the modulation of the deep (slow wave) sleep by playing short, low volume tones, the investigators want to test if there is a causal relationship between slow wave sleep and markers of cortical plasticity.

Interventions

OTHERPlaying tones during deep sleep

Playing tones time locked to slow waves (Duration:50ms, volume: 50dB)

in the sham condition, no tones will be played

Sponsors

University Children's Hospital, Zurich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
8 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Male and female subjects 8 to 30 years of age, * good general health Status * right-handedness, * Written informed consent after participants' information

Exclusion criteria

* sleep disorders (insomnia, sleep disordered breathing, restless legs syndrome) * sleep complaints in general * irregular sleep-wake rhythm * daytime sleep * travelling across a time zone within the last month * diseases or lesions of the central nervous system * psychiatric diseases * learning disability * skin allergy or very sensitive skin * acute pediatric disease * pregnancy * drug and medication use and abuse * nicotine use * high caffeine consumption (\>2 servings/day (\>160 mg caffeine); including coffee, tea, white and dark chocolate, coca cola, energy drink) * Alcohol consumption in children and adolescents under 16 years * high alcohol consumption in adults (\> 1 standard serving/day (\>14 mg Alcohol)) * high alcohol consumption in adolescents aged 16 years and above (\> 3-4 Standard servings per week)

Design outcomes

Primary

MeasureTime frameDescription
Diurnal changes in brain metabolites3 yearsconcentration of brain metabolites measured by MR spectroscopy change from evening to morning

Secondary

MeasureTime frameDescription
electrophysiological markers change in dependance of the diurnal variation of brain metabolites3 yearselectrophysiological markers (sleep EEG) change in dependance of the diurnal variation of brain metabolites
structural markers change in dependance of the diurnal variation of brain metabolites3 yearsstructural markers (MR volumes) change in dependance of the diurnal variation of brain metabolites

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026